Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses

Background/Aims: While recombinant adenoviruses are among the most widely-used gene delivery vectors and usually propagated in HEK-293 cells, generating recombinant adenoviruses remains time-consuming and labor-intense. We sought to develop a rapid adenovirus production and amplification (RAPA) line...

Full description

Bibliographic Details
Main Authors: Qiang Wei, Jiaming Fan, Junyi Liao, Yulong Zou, Dongzhe Song, Jianxiang Liu, Jing Cui, Feng Liu, Chao Ma, Xue Hu, Li Li, Yichun Yu, Xiangyang Qu, Liqun Chen, Xinyi Yu, Zhicai Zhang, Chen Zhao, Zongyue Zeng, Ruyi Zhang, Shujuan Yan, Xingye Wu, Yi Shu, Russell R. Reid, Michael J. Lee, Jennifer Moritis Wolf, Tong-Chuan He
Format: Article
Language:English
Published: Cell Physiol Biochem Press GmbH & Co KG 2017-05-01
Series:Cellular Physiology and Biochemistry
Subjects:
Online Access:http://www.karger.com/Article/FullText/475909
id doaj-c4ca44d8a1a645b2a67fa7fe4aaac1f2
record_format Article
spelling doaj-c4ca44d8a1a645b2a67fa7fe4aaac1f22020-11-24T21:31:44ZengCell Physiol Biochem Press GmbH & Co KGCellular Physiology and Biochemistry1015-89871421-97782017-05-014162383239810.1159/000475909475909Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant AdenovirusesQiang WeiJiaming FanJunyi LiaoYulong ZouDongzhe SongJianxiang LiuJing CuiFeng LiuChao MaXue HuLi LiYichun YuXiangyang QuLiqun ChenXinyi YuZhicai ZhangChen ZhaoZongyue ZengRuyi ZhangShujuan YanXingye WuYi ShuRussell R. ReidMichael J. LeeJennifer Moritis WolfTong-Chuan HeBackground/Aims: While recombinant adenoviruses are among the most widely-used gene delivery vectors and usually propagated in HEK-293 cells, generating recombinant adenoviruses remains time-consuming and labor-intense. We sought to develop a rapid adenovirus production and amplification (RAPA) line by assessing human Ad5 genes (E1A, E1B19K/55K, pTP, DBP, and DNA Pol) and OCT1 for their contributions to adenovirus production. Methods: Stable transgene expression in 293T cells was accomplished by using piggyBac system. Transgene expression was determined by qPCR. Adenoviral production was assessed with titering, fluorescent markers and/or luciferase activity. Osteogenic activity was assessed by measuring alkaline phosphatase activity. Results: Overexpression of both E1A and pTP led to a significant increase in adenovirus amplification, whereas other transgene combinations did not significantly affect adenovirus amplification. When E1A and pTP were stably expressed in 293T cells, the resultant RAPA line showed high efficiency in adenovirus amplification and production. The produced AdBMP9 infected mesenchymal stem cells with highest efficiency and induced most effective osteogenic differentiation. Furthermore, adenovirus production efficiency in RAPA cells was dependent on the amount of transfected DNA. Under optimal transfection conditions high-titer adenoviruses were obtained within 5 days of transfection. Conclusion: The RAPA cells are highly efficient for adenovirus production and amplification.http://www.karger.com/Article/FullText/475909Adenoviral vectorsAdenovirus productionPackaging cell lineGene transferGene delivery
collection DOAJ
language English
format Article
sources DOAJ
author Qiang Wei
Jiaming Fan
Junyi Liao
Yulong Zou
Dongzhe Song
Jianxiang Liu
Jing Cui
Feng Liu
Chao Ma
Xue Hu
Li Li
Yichun Yu
Xiangyang Qu
Liqun Chen
Xinyi Yu
Zhicai Zhang
Chen Zhao
Zongyue Zeng
Ruyi Zhang
Shujuan Yan
Xingye Wu
Yi Shu
Russell R. Reid
Michael J. Lee
Jennifer Moritis Wolf
Tong-Chuan He
spellingShingle Qiang Wei
Jiaming Fan
Junyi Liao
Yulong Zou
Dongzhe Song
Jianxiang Liu
Jing Cui
Feng Liu
Chao Ma
Xue Hu
Li Li
Yichun Yu
Xiangyang Qu
Liqun Chen
Xinyi Yu
Zhicai Zhang
Chen Zhao
Zongyue Zeng
Ruyi Zhang
Shujuan Yan
Xingye Wu
Yi Shu
Russell R. Reid
Michael J. Lee
Jennifer Moritis Wolf
Tong-Chuan He
Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
Cellular Physiology and Biochemistry
Adenoviral vectors
Adenovirus production
Packaging cell line
Gene transfer
Gene delivery
author_facet Qiang Wei
Jiaming Fan
Junyi Liao
Yulong Zou
Dongzhe Song
Jianxiang Liu
Jing Cui
Feng Liu
Chao Ma
Xue Hu
Li Li
Yichun Yu
Xiangyang Qu
Liqun Chen
Xinyi Yu
Zhicai Zhang
Chen Zhao
Zongyue Zeng
Ruyi Zhang
Shujuan Yan
Xingye Wu
Yi Shu
Russell R. Reid
Michael J. Lee
Jennifer Moritis Wolf
Tong-Chuan He
author_sort Qiang Wei
title Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
title_short Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
title_full Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
title_fullStr Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
title_full_unstemmed Engineering the Rapid Adenovirus Production and Amplification (RAPA) Cell Line to Expedite the Generation of Recombinant Adenoviruses
title_sort engineering the rapid adenovirus production and amplification (rapa) cell line to expedite the generation of recombinant adenoviruses
publisher Cell Physiol Biochem Press GmbH & Co KG
series Cellular Physiology and Biochemistry
issn 1015-8987
1421-9778
publishDate 2017-05-01
description Background/Aims: While recombinant adenoviruses are among the most widely-used gene delivery vectors and usually propagated in HEK-293 cells, generating recombinant adenoviruses remains time-consuming and labor-intense. We sought to develop a rapid adenovirus production and amplification (RAPA) line by assessing human Ad5 genes (E1A, E1B19K/55K, pTP, DBP, and DNA Pol) and OCT1 for their contributions to adenovirus production. Methods: Stable transgene expression in 293T cells was accomplished by using piggyBac system. Transgene expression was determined by qPCR. Adenoviral production was assessed with titering, fluorescent markers and/or luciferase activity. Osteogenic activity was assessed by measuring alkaline phosphatase activity. Results: Overexpression of both E1A and pTP led to a significant increase in adenovirus amplification, whereas other transgene combinations did not significantly affect adenovirus amplification. When E1A and pTP were stably expressed in 293T cells, the resultant RAPA line showed high efficiency in adenovirus amplification and production. The produced AdBMP9 infected mesenchymal stem cells with highest efficiency and induced most effective osteogenic differentiation. Furthermore, adenovirus production efficiency in RAPA cells was dependent on the amount of transfected DNA. Under optimal transfection conditions high-titer adenoviruses were obtained within 5 days of transfection. Conclusion: The RAPA cells are highly efficient for adenovirus production and amplification.
topic Adenoviral vectors
Adenovirus production
Packaging cell line
Gene transfer
Gene delivery
url http://www.karger.com/Article/FullText/475909
work_keys_str_mv AT qiangwei engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT jiamingfan engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT junyiliao engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT yulongzou engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT dongzhesong engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT jianxiangliu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT jingcui engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT fengliu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT chaoma engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT xuehu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT lili engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT yichunyu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT xiangyangqu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT liqunchen engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT xinyiyu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT zhicaizhang engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT chenzhao engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT zongyuezeng engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT ruyizhang engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT shujuanyan engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT xingyewu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT yishu engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT russellrreid engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT michaeljlee engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT jennifermoritiswolf engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
AT tongchuanhe engineeringtherapidadenovirusproductionandamplificationrapacelllinetoexpeditethegenerationofrecombinantadenoviruses
_version_ 1725960062861574144